These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4576 related articles for article (PubMed ID: 6528940)
1. Prediction of lymph node metastases from the histologic features of primary cutaneous malignant melanomas. Weissmann A; Roses DF; Harris MN; Dubin N Am J Dermatopathol; 1984; 6 Suppl():35-41. PubMed ID: 6528940 [TBL] [Abstract][Full Text] [Related]
2. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma. Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123 [TBL] [Abstract][Full Text] [Related]
3. Prognostic factors of cutaneous melanoma in relation to metastasis at the sentinel lymph node: a case-controlled study. Sartore L; Papanikolaou GE; Biancari F; Mazzoleni F Int J Surg; 2008 Jun; 6(3):205-9. PubMed ID: 18417434 [TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas. Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421 [TBL] [Abstract][Full Text] [Related]
6. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3). Nowecki ZI; Rutkowski P; Michej W Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535 [TBL] [Abstract][Full Text] [Related]
7. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma. Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039 [TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in patients with thick cutaneous melanoma (> 4 mm). Zettersten E; Sagebiel RW; Miller JR; Tallapureddy S; Leong SP; Kashani-Sabet M Cancer; 2002 Feb; 94(4):1049-56. PubMed ID: 11920475 [TBL] [Abstract][Full Text] [Related]
9. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma. Paek SC; Griffith KA; Johnson TM; Sondak VK; Wong SL; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS Cancer; 2007 Jan; 109(1):100-8. PubMed ID: 17146784 [TBL] [Abstract][Full Text] [Related]
10. [Anatomo-pathologic study of sentinel lymph nodes in melanoma. Analysis of 200 cases]. Riccioni L; Morigi F; Naldi S; Polverelli M; Morelli R; Fiscelli O; Landi G; Giangaspero F Pathologica; 1999 Aug; 91(4):242-8. PubMed ID: 10630072 [TBL] [Abstract][Full Text] [Related]
11. A model for pretest probability of lymph node metastasis from cutaneous Melanoma. Vollmer RT; Seigler HF Am J Clin Pathol; 2000 Dec; 114(6):875-9. PubMed ID: 11338476 [TBL] [Abstract][Full Text] [Related]
12. [Prognosis of malignant melanoma following dissection regional lymph node metastases]. Sprakel B; Stenschke F; Unnewehr M; Ladas A; Senninger N Chirurg; 2003 Jan; 74(1):55-60. PubMed ID: 12552406 [TBL] [Abstract][Full Text] [Related]
13. Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma. Page AJ; Carlson GW; Delman KA; Murray D; Hestley A; Cohen C Am Surg; 2007 Jul; 73(7):674-8; discussion 678-9. PubMed ID: 17674939 [TBL] [Abstract][Full Text] [Related]
14. Regional lymph node dissections in malignant melanoma. Lawton GP; Ariyan S Clin Plast Surg; 2000 Jul; 27(3):431-40, ix. PubMed ID: 10941563 [TBL] [Abstract][Full Text] [Related]
15. Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma? Frankel TL; Griffith KA; Lowe L; Wong SL; Bichakjian CK; Chang AE; Cimmino VM; Bradford CR; Rees RS; Johnson TM; Sabel MS Ann Surg Oncol; 2008 Sep; 15(9):2403-11. PubMed ID: 18626721 [TBL] [Abstract][Full Text] [Related]
16. Sentinel node identification by scintigraphic methods in cutaneous melanoma. Dias Moreira R; Altino de Almeida S; Maliska GuimarĂ£es CM; Resende JF; Gutfilen B; Barbosa da Fonseca LM J Exp Clin Cancer Res; 2005 Jun; 24(2):181-5. PubMed ID: 16110749 [TBL] [Abstract][Full Text] [Related]
17. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma]. Keijzer R; Bril H; van der Loo EM; de Graaf PW Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391 [TBL] [Abstract][Full Text] [Related]
18. [Prognostic factors in thin cutaneous malignant melanoma]. Massi D; Franchi A; Santucci M Pathologica; 2002 Dec; 94(6):282-9. PubMed ID: 12540991 [TBL] [Abstract][Full Text] [Related]
19. Detection of occult melanoma cells in sentinel lymph nodes and blood. Reintgen DS; Conrad AJ Semin Oncol; 1997 Feb; 24(1 Suppl 4):S11-5. PubMed ID: 9122728 [TBL] [Abstract][Full Text] [Related]